RecruitingNot ApplicableNCT05671419

Mindful Self-Compassion for Anxiety Disorders and Depression


Sponsor

Georgetown University

Enrollment

40 participants

Start Date

Jan 16, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The study will compare 8-week Mindful Self-Compassion training, compared to a control group that does not receive the intervention, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a program called Mindful Self-Compassion (MSC) — which teaches people to treat themselves with kindness and reduce self-criticism — can reduce anxiety and depression symptoms in people who score low on self-compassion. **You may be eligible if...** - You have a primary diagnosis of an anxiety disorder (social anxiety, generalized anxiety, panic disorder, or agoraphobia) or major depressive disorder - You score low on a self-compassion measure - You are willing and able to attend all testing visits and treatment sessions **You may NOT be eligible if...** - You have another psychiatric condition beyond anxiety or depression (such as psychosis, obsessive compulsive disorder, or an eating disorder) - You are unable to give informed consent - You are currently in another psychotherapy treatment that could interfere with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMindful Self-Compassion

The course teaching mindfulness meditation skills relevant to cultivating self-compassion.


Locations(1)

Georgetown University Medical Center

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05671419


Related Trials